http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cca412cf001e343d86c85a065f541a8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Golub |
| name | Todd R Golub Todd R. Golub |
| given-name | Todd R Todd R. |
| organization-name | From the Departments of Medical Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; the Broad Institute of the Massachusetts Institute of Technology and Harvard; and the Howard Hughes Medical Institute. Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA From the Departments of Adult Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston; and Whitehead Institute/MIT Center for Genome Research, Cambridge, MA. Authors' Affiliations: 1Departments of Biostatistics and Computational Biology and 2Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; 3Departments of Biostatistics and 4Epidemiology and Nutrition, Harvard School of Public Health; 5Department of Pathology and 6Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston; 7Broad Institute of Harvard and MIT, Cambridge, Massachusetts; 8Mount Sinai Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York; 9The University of Queensland, UQ Centre for Clinical Research, and 10The University of Queensland, School of Medicine, Herston; and 11Pathology Queensland: The Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142; Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, Cambridge, MA 02142; Cambridge Institute for Medical Research, Cambridge University, Hills Road, Cambridge CB2 2XY, United Kingdom; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142; Department of Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Harvard Medical School, Boston,... Authors' Affiliations: 1Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts; 2Department of Medicine, Hematology-Oncology Unit, Massachusetts General Hospital; 3The Pediatric Service, Massachusetts General Hospital and the Massachusetts General Hospital Cancer Center; 4Harvard Stem Cell Institute, Brigham and Women's Hospital, Boston, Massachusetts; and 5The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts Dana-Farber/Boston Children’s Cancer and Blood Disorders Center , Boston, Massachusetts , USA; Broad Institute of Harvard and MIT , Cambridge, Massachusetts , USA Children's Hospital, 300 Longwood Avenue, Boston, MA 02115; Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115; Oregon State University, Corvallis, OR 97333; Department of Biostatistical Science, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; and The Broad Institute of MIT and Harvard, Cambridge, MA 02141 2Pediatric Oncology and; 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School;; 5The Broad Institute of M.I.T. and Harvard; *Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston, Harvard Medical School, Boston, MA 02115;; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142;; Howard Hughes Medical Institute, Chevy Chase, MD 20815; and Broad Institute of Harvard and Massachusetts Institute Technology, Cambridge, MA 02142;; The Dana-Farber Cancer Institute,; The Howard Hughes Medical Institute, Chevy Chase, MD 20815; and 2Pediatric Oncology and 2Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; 11Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 12Howard Hughes Medical Institute, Chevy Chase, Maryland. 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; 3Harvard Medical School, Boston, Massachusetts.; 4Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts. Center for Genome Research, Whitehead Institute for Biomedical Research, Cambridge, MA 02139; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115 The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, 320 Charles Street, Cambridge, MA 02141; and Dana–Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115 From the Division of Hematology-Oncology, Brigham and Women’s Hospital, Department of Pediatric Oncology the Dana-Farber Cancer Institute, and the Howard Hughes Medical Institute, Harvard Medical School, Boston, MA. Broad Institute of MIT and Harvard, Cambridge, MA 8 Broad Institute, Cambridge, MA;; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 1Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts;; 2Pediatric Oncology, Dana-Farber Cancer Institute;; 3Children's Hospital Boston, Harvard Medical School;; 4Howard Hughes Medical Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Division of Hematology and Oncology, Brigham and Women’s Hospital, The Division of Pediatric Oncology, Dana–Farber Cancer Institute, and The Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts2Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142;; Howard Hughes Medical Institute, Bethesda, MD 20817; and; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215 Departments of Obstetrics and Gynecology and Biochemistry and Molecular Genetics, University Colorado Health Sciences Center, Denver, CO 80262; Discipline of Pathology, University of Campinas Dental School, 13414-018 Piracicaba-SP, Brazil; Howard Hughes Medical Institute and Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, One Kendall Square, Cambridge, MA 02139; Department of Cancer Biology and Pediatric Oncology, Dana–Farber Cancer Institute and Harvard Medical... The Dana-Farber Cancer Institute, Boston, MA 02115;; Broad Institute, Cambridge, MA 02142;; Childrens Hospital, Boston, MA 02115;; The Howard Hughes Medical Institute, Boston, MA 02115 1Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; 6Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. From Harvard School of Public Health; Harvard Medical School; Harvard Radiation Oncology Program; Channing Laboratory, Brigham and Women's Hospital; Dana-Farber Cancer Institute, Boston; The Broad Institute, Cambridge; MA; Uppsala University, Uppsala; Karolinska Institutet, Stockholm; Örebro University Hospital, Örebro, Sweden; Comprehensive Cancer Center, University Hospital of Tuebingen, Tuebingen, Germany; University of Brescia, Brescia, Italy; and Weill Cornell Medical College, New York, NY. Broad Institute of Harvard University and the Massachusetts Institute of Technology, Cambridge, MA;; Children's Hospital, Harvard Medical School, Boston, MA;; Howard Hughes Medical Institute, Chevy Chase, MD; and Broad Institute of Harvard and MIT, Cambridge, MA 02142; Departments of Medical Oncology and Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115;; The Broad Institute, Harvard Medical School and Massachusetts Institute of Technology, Cambridge, MA 02141; and Broad Institute of MIT and Harvard, Cambridge, MA 02142; Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, and the Broad Institute of Harvard and MIT, Cambridge, Massachusetts;; Department of Medicine, Children's Hospital Boston, Boston, Massachusetts, and Howard Hughes Medical Institute, Chevy Chase, Maryland From the Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston, Harvard Medical School, Boston, MA; The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA; Howard Hughes Medical Institute, Chevy Chase, MD; and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Genome Center at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; Dana-Farber Cancer Institute and the Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 2The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts; and Broad Institute, Cambridge, MA; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, and Harvard Medical School, Boston, Massachusetts 02115; Department of Medicine, Children's Hospital Boston, Boston, Massachusetts 02115, and Howard Hughes Medical Institute, Chevy Chase, Maryland 20815 Department of Pediatric Oncology, Dana–Farber Cancer Institute and Children’s Hospital, Harvard Medical School, Boston, MA 02115;; The Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02141; Children's Hospital Informatics Program and Division of Endocrinology, Department of Medicine, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115; Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142; and Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02214, USA.; Harvard Medical School, Boston, MA 02115, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Harvard Medical School, Boston, MA;; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA;; Dana-Farber Cancer Institute, Boston, MA Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA, 02142 Broad Institute of Massachusetts Institute of Technology and Harvard, 7 Cambridge Center, Cambridge, MA 02142;; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115;; The Howard Hughes Medical Institute, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; and Division of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; Division of Hematology/Oncology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Medicine, Children's Hospital Boston, Boston, MA 02115, USA.; Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02144, USA.; Harvard Medical School, Boston, MA 02115, USA. Cancer Program; Broad Institute; Cambridge MA; Dana-Farber Cancer Institute and Harvard Medical School; Boston MA; Howard Hughes Medical Institute; Boston MA Center for Genome Research, The Broad Institute of MIT and Harvard, 320 Charles Street, Cambridge, Massachusetts 02141-2023 4Center for Genome Research, Whitehead Institute/Massachusetts Institute of Technology, Cambridge, Massachusetts; *Department of Pediatric Oncology and; ‡Division of Hematology/Oncology, Children’s Hospital, Boston, MA 02115;; §Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142; Daniel G. Stover, Ohio State University Comprehensive Cancer Center, Columbus, OH; Heather A. Parsons, Gavin Ha, William T. Barry, Hao Guo, Atish D. Choudhury, Melissa E. Hughes, Deborah A. Dillon, Ann H. Partridge, Nikhil Wagle, Ian E. Krop, Todd R. Golub, Eric P. Winer, Sara M. Tolaney, and Nancy U. Lin, Dana-Farber Cancer Institute; Gad Getz, Massachusetts General Hospital, Boston; Gavin Ha, Samuel S. Freeman, Atish D. Choudhury, Gregory Gydush, Sarah C. Reed, Justin Rhoades, Denisse Rotem, Nikhil... 1Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 4Harvard Medical School, Boston, Massachusetts.; 5Howard Hughes Medical Institute, Chevy Chase, Maryland. Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 Broad Institute of Massachusetts Institute of Technology and Harvard, 320 Charles Street, Cambridge, MA 02141;Department of Systems Biology, Alpert 536, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02446; Institute for Genome Sciences and Policy, Center for Interdisciplinary Engineering, Medicine, and Applied Sciences, Duke University, 101 Science Drive, Durham, NC 27708; Department of Medical Oncology, Dana–Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; Division of... The Broad Institute of MIT and Harvard, Cambridge, MA 02142;; Department of Pediatrics,; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Broad Institute of Massachusetts Institute of Technology and HarvardCambridgeMassachusettsUSA Eli and Edythe Broad Institute, Cambridge, MA 02412;; Dana–Farber Cancer Institute, Boston, MA 02115;; Harvard Medical School, Boston, MA 02115;; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Cancer Program, Broad Institute, Cambridge, MA 02142; and Departments of Adult Oncology and Pediatric Oncology, Dana–Farber Cancer Institute, Harvard Medical School, and Department of Biostatistics, Harvard School of Public Health, 44 Binney Street, Boston, MA 02115; Departments of Surgery and Pathology, Brigham and Women's Hospital, HMS, 75 Francis Street, Boston, MA 02115; Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, 1 Kendall Square, Cambridge, MA 02139; and Department of Pathology, Massachusetts General Hospital... Departments of Pharmacology and Toxicology and Medicine, and Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH 03755; Dana Farber Cancer Institute, Boston, MA 02115; and Whitehead Institute for Biomedical Research, Cambridge, MA 02139 Broad Institute, Cambridge, MA 02141;; Department of Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115;; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115 Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142; Dana–Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH 03755; and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 Whitehead/Massachusetts Institute of Technology Center for Genome Research, Cambridge, MA 02139; Laboratory of Molecular Pharmacology, Division of Basic Sciences, Building 37/5D-02, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115 Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston, Harvard Medical School, MA;; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge;; Howard Hughes Medical Institute, Chevy Chase, MD From the Departments of Medical Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and the Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA. Departments of Medical Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, and Departments of Medicine and Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Medical School, Boston, MA 02115, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States; Dana-Farber Cancer Institute and Howard Hughes Medical Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142;; The Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115;; Yale Stem Cell Center, Department of Genetics, Yale University, New Haven, CT 06520 1Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; 2Eli and Edythe L. Broad Institute, Cambridge, Massachusetts. The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. 5Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; 9Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; 10Howard Hughes Medical Institute, Chevy Chase, Maryland. Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142; Department of Anatomy and Reproductive Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96822; Department of Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; and Department of Pediatrics, Harvard Medical School, Boston, MA 02115 3Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Departments of; 8Broad Institute of MIT and Harvard and; 9Howard Hughes Medical Institute, Cambridge, Massachusetts Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; Dana-Farber Cancer Institute and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142;; Department of Medical Oncology and Center for Cancer Genome Discovery and; Departments of fBiostatistics and Computational Biology and; Pediatric Oncology, Dana–Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; Center for Genome Research, Whitehead Institute, Cambridge, Massachusetts 02139 Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02141;; Department of Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115;; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.; Department of Statistics, Stanford University, Stanford, CA 94305, USA.; Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Medicine, Children's Hospital Boston, Boston, MA 02115, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, Cambridge, MA 02138; Departments of Adult and Pediatric Oncology, Dana–Farber Cancer Institute/Harvard Medical School, Boston, MA 02115; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115; Department of Pathology, Memorial Sloan–Kettering Cancer Center, New York, NY 10021; and Departments of Biology, McGovern Institute, Center for Brain and Computational Learning, and Artificial ... Cancer Biology Program, |
Incoming Links
Showing number of triples: 1 to 312 of 312.